July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Open Lending Corporation (“Open Lending” or “the Company”) (NASDAQ: LPRO). Investors who purchased Open Lending securities prior to February 24, 2022, and continue to hold to the present, are encouraged to… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NAPCO Security Technologies, Inc. (“NAPCO” or “the Company”) (NASDAQ: NSSC). Investors who purchased NAPCO securities prior to February 5, 2024, and continue to hold to the present, are encouraged to obtain… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. (“Avis Budget” or “the Company”) (NASDAQ: CAR). Investors who purchased Avis Budget securities prior to February 13, 2024, and continue to hold to the present, are encouraged… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sana Biotechnology, Inc. (“Sana” or “the Company”) (NASDAQ: SANA). Investors who purchased Sana securities prior to March 17, 2023, and continue to hold to the present, are encouraged to obtain additional… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Solaris Energy Infrastructure, Inc. (“Solaris” or “the Company”) (NYSE: SEI). Investors who purchased Solaris securities prior to July 9, 2024, and continue to hold to the present, are encouraged to obtain… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Firsthand Technology Value Fund, Inc. (“Firsthand Technology” or “the Company”) (OTCMKTS: SVVC). Investors who purchased Firsthand Technology securities prior to January 1, 2021, and continue to hold to the present, are… read more
July 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Harrow, Inc. (“Harrow” or “the Company”) (NASDAQ: HROW). Investors who purchased Harrow securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Harrow has violated federal… read more
July 3, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of National Grid plc (“National Grid” or “the Company”) (NYSE: NGG). Investors who purchased National Grid securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether National… read more
July 2, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of American Outdoor Brands, Inc. (“American Outdoor” or “the Company”) (NASDAQ: AOUT). Investors who purchased American Outdoor securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
July 2, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Altimmune, Inc. (“Altimmune” or “the Company”) (NASDAQ: ALT). Investors who purchased Altimmune securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Altimmune has violated federal… read more
June 24, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Designer Brands Inc. (“Designer Brands” or “the Company”) (NYSE: DBI). Investors who purchased Designer Brands securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Designer… read more
June 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dyne Therapeutics, Inc. (“Dyne” or “the Company”) (NASDAQ: DYN). Investors who purchased Dyne securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Dyne has violated… read more
June 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hallador Energy Company (“Hallador” or “the Company”) (NASDAQ: HNRG). Investors who purchased Hallador securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Hallador has violated… read more
June 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sanofi (“Sanofi” or “the Company”) (NASDAQ: SNY). Investors who purchased Sanofi securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sanofi has violated federal securities… read more
June 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Caleres, Inc. (“Caleres” or “the Company”) (NYSE: CAL). Investors who purchased Caleres securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Caleres has violated federal… read more
June 12, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gilead Sciences, Inc. (“Gilead” or “the Company”) (NASDAQ: GILD). Investors who purchased Gilead securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Gilead has violated… read more
June 10, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Abacus Global Management, Inc. (“Abacus” or “the Company”) (NASDAQ: ABL). Investors who purchased Abacus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Abacus has… read more
June 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NWTN Inc. (“NWTN” or “the Company”) (NASDAQ: NWTN). Investors who purchased NWTN securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether NWTN has violated federal… read more
June 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Brown-Forman Corporation (“Brown-Forman” or “the Company”) (NYSE: BF-A, BF-B). Investors who purchased Brown-Forman securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Brown-Forman has violated… read more
June 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb Corporation (“Bausch + Lomb” or “the Company”) (NYSE: BLCO). Investors who purchased Bausch + Lomb securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
June 4, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of New Fortress Energy, Inc. (“New Fortress” or “the Company”) (NASDAQ: NFE). Investors who purchased New Fortress securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
May 29, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NeuroPace, Inc. (“NeuroPace” or “the Company”) (NASDAQ: NPCE). Investors who purchased NeuroPace securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether NeuroPace has violated federal… read more
May 28, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AlloVir Inc. (“AlloVir” or “the Company”) (NASDAQ: ALVR). Investors who purchased AlloVir securities prior to March 22, 2022, and continue to hold to the present, are encouraged to obtain additional information… read more
May 26, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulgent Genetics, Inc. (“Fulgent” or “the Company”) (NASDAQ: FLGT). Investors who purchased Fulgent securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Fulgent has violated… read more
May 26, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flowco Holdings Inc. (“Flowco” or “the Company”) (NYSE: FLOC). Investors who purchased Flowco securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Flowco has violated… read more
May 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Schrödinger, Inc. (“Schrödinger” or “the Company”) (NASDAQ: SDGR). Investors who purchased Schrödinger securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Schrödinger has violated federal… read more
May 20, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Travere Therapeutics, Inc. (“Travere” or “the Company”) (NASDAQ: TVTX). Investors who purchased Travere securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Travere has violated… read more
May 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Meta Platforms, Inc. (“Meta” or “the Company”) (NASDAQ: META). Investors who purchased Meta securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Meta has violated… read more
May 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. (“GoHealth” or “the Company”) (NASDAQ: GOCO). Investors who purchased GoHealth securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether GoHealth has violated federal… read more
May 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Metallus Inc. (“Metallus” or “the Company”) (NYSE: MTUS). Investors who purchased Metallus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Metallus has violated federal… read more